» Articles » PMID: 1869494

Elimination of Mycoplasmas from Cell Cultures by a Novel Soft Agar Technique

Overview
Date 1991 Jun 1
PMID 1869494
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Mycoplasmal infection of cell cultures remains a significant threat to diagnostic and research procedures. In certain defined situations, curing of mycoplasmal infected cultures is a reasonable exercise. Four methods of curing were compared: treatment with BM-cycline, 5 bromouracil, use of specific antisera and treatment of infected cells suspended in soft agar with antibiotics. Antisera treatments were of low efficiency of curing: 50%. None of nine infected cell lines treated with 5-bromouracil were consistently cured of mycoplasmas. The use of BM-cycline was effective for some, but not all lines and required long periods of treatment, 12-21 days. 35 naturally or deliberately infected cultures were treated in soft agar a total of 119 times. This procedure which consisted of suspending infected cultures in soft agar containing appropriate antibiotics resulted in successful mycoplasmal elimination 118/119 times. This soft agar technique took 1-3 days. In separate studies, it was shown that certain Mycoplasma fermentans strains were resisted to this and other curing methods. This may be due to their intracellular location. Such strains may be more amenable to antibiotics that penetrate mammalian cells. It is concluded that the soft agar technique is a rapid, efficient and reliable method to eliminate cell culture mycoplasmas.

Citing Articles

Effect of antibiotics against Mycoplasma sp. on human embryonic stem cells undifferentiated status, pluripotency, cell viability and growth.

Romorini L, Riva D, Bluguermann C, Videla Richardson G, Scassa M, Sevlever G PLoS One. 2013; 8(7):e70267.

PMID: 23936178 PMC: 3728093. DOI: 10.1371/journal.pone.0070267.


PCR-based detection and eradication of mycoplasmal infections from various mammalian cell lines: a local experience.

Molla Kazemiha V, Shokrgozar M, Arabestani M, Moghadam M, Azari S, Maleki S Cytotechnology. 2010; 61(3):117-24.

PMID: 20135349 PMC: 2825298. DOI: 10.1007/s10616-010-9252-6.


Arginine consumption as a monitor of mycoplasma infection of cultured cells.

Capiaumont J, LeGrand C, Dousset B, Belleville F, NABET P In Vitro Cell Dev Biol Anim. 1995; 31(7):497-8.

PMID: 8528497 DOI: 10.1007/BF02634026.


Treatment of mycoplasma contamination in a large panel of cell cultures.

Drexler H, Gignac S, Hu Z, Hopert A, FLECKENSTEIN E, Voges M In Vitro Cell Dev Biol Anim. 1994; 30A(5):344-7.

PMID: 8069460 DOI: 10.1007/BF02631456.


Use of ciprofloxacin and BM-Cyclin in mycoplasma decontamination.

Somasundaram C, Nicklas W, Matzku S In Vitro Cell Dev Biol. 1992; 28A(11-12):708-10.

PMID: 1483961 DOI: 10.1007/BF02631057.

References
1.
Marcus M, Lavi U, Nattenberg A, Rottem S, Markowitz O . Selective killing of mycoplasmas from contaminated mammalian cells in cell cultures. Nature. 1980; 285(5767):659-61. DOI: 10.1038/285659a0. View

2.
Kotani H, McGarrity G . Rapid and simple identification of mycoplasmas by immunobinding. J Immunol Methods. 1985; 85(2):257-67. DOI: 10.1016/0022-1759(85)90136-x. View

3.
McGarrity G, Vanaman V, Sarama J . Cytogenetic effects of mycoplasmal infection of cell cultures: a review. In Vitro. 1984; 20(1):1-18. DOI: 10.1007/BF02633326. View

4.
Lo S, Dawson M, Wong D, Newton 3rd P, Sonoda M, Engler W . Identification of Mycoplasma incognitus infection in patients with AIDS: an immunohistochemical, in situ hybridization and ultrastructural study. Am J Trop Med Hyg. 1989; 41(5):601-16. DOI: 10.4269/ajtmh.1989.41.601. View

5.
Kotani H, BUTLER G, Tallarida D, Cody C, McGarrity G . Microbiological cultivation of Mycoplasma hyorhinis from cell cultures. In Vitro Cell Dev Biol. 1990; 26(1):91-6. DOI: 10.1007/BF02624161. View